SEC Form 4 · accession 0001203311-17-000074
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 6, 2017 | M | 5,024 | $16.41 | A | 77,230 | D | |
| Common StockF1 | Sep 6, 2017 | M | 5,024 | $15.46 | A | 82,254 | D | |
| Common StockF1 | Sep 6, 2017 | S | 5,024 | $51.944 | D | 77,230 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $16.41 | Sep 6, 2017 | M | 5,024 | D | — | Oct 29, 2020 | Common Stock | 5,024 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $15.46 | Sep 6, 2017 | M | 5,024 | D | — | Aug 24, 2021 | Common Stock | 5,024 | 2,268 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Shares vested at a rate of 25% on October 29, 2011 and monthly thereafter until all the shares are fully vested on October 29, 2014.
- F3Shares vested at a rate of 25% on August 24, 2012 and monthly thereafter until all the shares are fully vested on August 24, 2015.